- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00664950
InterTAN IM Nail Versus Sliding Hip Screw in Geriatric Fractures
A Multi-centre Randomized Control Trail Comparing a Novel Intramedullary Device (InterTAN) Versus Conventional Treatment (Sliding Hip Screw) of Geriatric Fractures.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Outcome after hip fracture in the elderly is generally poor. According to the World Health Organization, fracture of the hip is associated with 20 % 1-year mortality and 50 % loss of function33. However, the high mortality and loss of function can be improved. For example, numerous studies have shown improvement in relevant outcomes when interventions such as improved thromboprophylaxis, care pathways and timely surgery are achieved. Up to 50 % decreases in mortality can be achieved with these interventions1,2,3.
While improvements in perioperative care can improve outcome, the benefit of newer surgical techniques and implants is less clear. This is well demonstrated in the case of intertrochanteric fractures. Intertrochanteric fractures are those in which the primary fracture line occurs between the greater and lesser trochanter and include approximately 50 % of all hip fractures. Many surgical implants have been developed for this common fracture pattern; in general, the conventional implant is a sliding hip screw (SHS) in which a plate is fixed to the lateral cortex of the femur, distal to the fracture; and a large-diameter screw is placed in the centre of the femoral head, proximal to the fracture. The screw and plate slide relative to one another, permitting compression of the fracture and facilitating bone healing. In contrast, the newer implants are typically intramedullary nail designs (IMN), in which a metal nail is placed within the canal of the femur and a large-diameter screw is placed in the centre of the femoral head. The theoretical advantage of newer designs is based upon, first, an improved stability of the implant, allowing earlier and more aggressive mobilization; and second, a less invasive surgical procedure to minimize blood loss. Nonetheless, repeated trials and meta-analyses have failed to demonstrate an advantage to the IMN designs compared to SHS. In fact, perioperative complications seem to be higher using the IMN designs4,5.
There are two primary reasons why IMN designs have not translated into improved results to date. First, perioperative complications, especially fractures of the femur, are more common with current IMN designs. Second, the supposed improved stability conferred by these devices may not actually be achieved. Current IMN designs retain the original concept of a single screw in the femoral head, which does not prevent rotation of the femoral head - a common reason for implant failure. As well, most current IMN designs permit unrestricted axial shortening of the femur, which may lead to significant leg length changes and alter gait.
A new implant has been designed to take advantage of the inherent theoretical strengths of IMN designs and improve upon current design flaws. The InterTAN device (IT) has been designed to improve stability after fixation of intertrochanteric fractures. This device has a double proximal hip screw, to achieve rotational control; improved implant geometry, to improve immediate stability; and immediate compression to achieve stability while avoiding uncontrolled leg length changes. The IT device retains the percutaneous insertion technique of other IMN devices and simplifies insertion with redesigned instrumentation. The InterTAN device is the first device designed specifically to provide enhanced stability to intertrochanteric fractures and seems to offer significant promise compared to other IM designs.
The InterTAN device has not, as of yet, been compared to conventional surgical techniques. According to the Cochrane Database Reviews, "Any new design should be evaluated in a randomised comparison with the sliding hip screw."
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Brunswick
-
Saint John, New Brunswick, Canada
- Saint John Regional Hosptial
-
-
Ontario
-
London, Ontario, Canada, N6A 4G5
- London Health Sciences Centre
-
Ottawa, Ontario, Canada
- Ottawa Civic Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 55 years or greater*
- Intertrochanteric fracture amenable to treatment by sliding hip screw or intramedullary nail fixation
- Previously ambulatory (defined as not usually requiring a wheelchair for ambulation)*
- Provision of informed consent*
- Surgery performed within 72 hours of admission
Exclusion Criteria:
- Cognitive or language barriers that would limit completion of assessment tests in English*
- Anticipated problems with follow-up in the judgment of the resident, or attending surgeon (e.g of no fixed address)*
- Surgeon refusal to randomize patient
- Pathologic fractures
- Polytrauma that would impact functional assessments in the opinion of the surgeon
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: SHS
sliding hip screw
|
surgical repair of hip fracture using conventional sliding hip screw
|
Active Comparator: InterTAn IM Nail
interTAN IM nail
|
interTAN IM nail
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Functional Independence Measure (FIM)
Time Frame: prospective
|
prospective
|
Timed up an go (TUG)
Time Frame: prospective
|
prospective
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
2-minute walk test (2MWT)
Time Frame: prospective
|
prospective
|
Geriatric Depression Scale (GDS)
Time Frame: prospective
|
prospective
|
Lower Extremity Measure (LEM)
Time Frame: prospective
|
prospective
|
Complications
Time Frame: prospective
|
prospective
|
Femoral shortening
Time Frame: prospective
|
prospective
|
Blood Loss
Time Frame: prospective
|
prospective
|
Mortality
Time Frame: prospective
|
prospective
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: David Sanders, MD, Lawson Health Research Institute
- Principal Investigator: Dianne Bryant, Western University, Canada
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R-08-002
- 13619 (Other Identifier: FDA IND)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Fractures
-
Smith & Nephew, Inc.Terminated
-
Carilion ClinicCompleted
-
Texas Tech University Health Sciences Center, El...CompletedHip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)United States
-
FH ORTHORecruitingHip Fractures | Hip DiseaseFrance
-
Zhenjiang First People's HospitalCompletedHip Fractures | Hip DiseaseChina
-
Bayside HealthCompleted
-
Oslo University HospitalDiakonhjemmet HospitalCompletedHip Fractures | Trochanteric Fractures | Intertrochanteric FracturesNorway
-
Tel-Aviv Sourasky Medical CenterUnknownIntertrochanteric Fractures of the HipIsrael
-
University of Missouri-ColumbiaUniversity of Alabama at Birmingham; Medical College of Wisconsin; University...CompletedHip Fractures | Pelvic Fractures | Acetabular FracturesUnited States
-
Rabin Medical CenterUnknown
Clinical Trials on sliding hip screw
-
Peterborough and Stamford Hospitals NHS Foundation...Completed
-
University Hospital WaterfordDePuy SynthesRecruitingHip Fractures | Gait, Unsteady | FunctionIreland
-
Stryker Trauma GmbHGlobal Research Solutions; Stryker OsteosynthesisCompletedFemoral Neck Fractures | Intertrochanteric FractureSweden, Denmark, Canada
-
Stryker Trauma GmbHGlobal Research SolutionsCompletedFemoral Neck Fractures | Intertrochanteric FractureUnited States, United Kingdom, Canada, Denmark, Germany, Australia, China, Colombia, Japan, Netherlands, Norway, South Africa
-
Oslo University HospitalDiakonhjemmet HospitalCompletedHip Fractures | Trochanteric Fractures | Intertrochanteric FracturesNorway
-
Smith & Nephew Orthopaedics AGTerminated
-
University of MinnesotaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedFemoral Neck FracturesUnited States
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalCompletedHip Fractures | Osteoporotic Fractures
-
University Hospital, ToursCompletedOther Reconstructive SurgeryFrance
-
Sohag UniversityRecruiting